The risk of developing prostate cancer in entacapone and levodopa/DDCI users compared to levodopa/DDCI users without entacapone - A nation-wide retrospective register-based study

ENCePP Code of conduct

No

ENCePP Seal

Signed code of conduct

ENCePP_Annex3_DeclarationSignaturePage

Signed code of conduct checklist

ENCePP_Annex2_Checklist

ENCePP_Annex2_ChecklistSignaturePage

Signed checklist for study protocols

ENCePPChecklistforStudyProtocolsSignaturePage

EUPAS2612-2625

Data sources

• Data sources (types):
  Administrative data (e.g. claims)

  Drug dispensing/prescription data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No